Renaissance Technologies’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$92.2K Sell
132,154
-537,310
-80% -$375K ﹤0.01% 3312
2025
Q1
$730K Buy
669,464
+102,841
+18% +$112K ﹤0.01% 2579
2024
Q4
$567K Buy
566,623
+177,542
+46% +$178K ﹤0.01% 2784
2024
Q3
$642K Buy
389,081
+97,994
+34% +$162K ﹤0.01% 2668
2024
Q2
$323K Sell
291,087
-456,184
-61% -$506K ﹤0.01% 2882
2024
Q1
$986K Buy
747,271
+672,465
+899% +$887K ﹤0.01% 2495
2023
Q4
$112K Sell
74,806
-502,594
-87% -$752K ﹤0.01% 3276
2023
Q3
$849K Buy
577,400
+422,500
+273% +$621K ﹤0.01% 2413
2023
Q2
$389K Sell
154,900
-222,560
-59% -$559K ﹤0.01% 3002
2023
Q1
$562K Buy
+377,460
New +$562K ﹤0.01% 2820
2022
Q4
Sell
-130,665
Closed -$413K 4248
2022
Q3
$413K Buy
130,665
+101,465
+347% +$321K ﹤0.01% 3042
2022
Q2
$101K Buy
+29,200
New +$101K ﹤0.01% 3850
2021
Q4
Sell
-16,700
Closed -$148K 4057
2021
Q3
$148K Buy
+16,700
New +$148K ﹤0.01% 3262
2021
Q1
Sell
-13,400
Closed -$205K 3491
2020
Q4
$205K Sell
13,400
-22,000
-62% -$337K ﹤0.01% 3130
2020
Q3
$657K Sell
35,400
-124,531
-78% -$2.31M ﹤0.01% 2718
2020
Q2
$1.94M Buy
159,931
+92,000
+135% +$1.11M ﹤0.01% 2201
2020
Q1
$411K Buy
67,931
+7,300
+12% +$44.2K ﹤0.01% 2853
2019
Q4
$588K Buy
60,631
+18,602
+44% +$180K ﹤0.01% 2839
2019
Q3
$420K Buy
42,029
+28,300
+206% +$283K ﹤0.01% 2931
2019
Q2
$157K Buy
13,729
+13,411
+4,217% +$153K ﹤0.01% 3340
2019
Q1
$3K Buy
+318
New +$3K ﹤0.01% 3414
2018
Q2
Sell
-565
Closed -$154K 3399
2018
Q1
$154K Sell
565
-1,168
-67% -$318K ﹤0.01% 3217
2017
Q4
$412K Buy
1,733
+373
+27% +$88.7K ﹤0.01% 2928
2017
Q3
$275K Buy
+1,360
New +$275K ﹤0.01% 2927
2015
Q3
Sell
-447
Closed -$377K 3250
2015
Q2
$377K Buy
+447
New +$377K ﹤0.01% 2805